CTLA4 and cancer: Over the past decade, immunotherapy has revolutionized cancer treatment, mainly by immune checkpoint inhibitors, such as nivolumab (anti-PD1) and ipilimumab (anti-CTLA4) [1], but also by adoptive immune cell therapies [2] and therapeutic cancer vaccines [3].